| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.04 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.079 | 0.04 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.15 | 0.05 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.05 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |